These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12833015)

  • 21. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
    Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
    Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
    Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
    J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
    Harries AD; Zachariah R; Lawn SD
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidemiology of glucocorticoid-associated adverse events.
    McDonough AK; Curtis JR; Saag KG
    Curr Opin Rheumatol; 2008 Mar; 20(2):131-7. PubMed ID: 18349741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
    Rabinowitz I; Tamir A
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness of prophylaxis against tuberculosis in patients infected with HIV].
    Arbeláez MP; Arbeláez A; Gómez RD; Rojas C; Vélez L; Arias SL; Nagles J; Peláez LM; Betancourt G; Velásquez G
    Biomedica; 2007 Dec; 27(4):515-25. PubMed ID: 18320119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy.
    Sester U; Junker H; Hodapp T; Schütz A; Thiele B; Meyerhans A; Köhler H; Sester M
    Nephrol Dial Transplant; 2006 Nov; 21(11):3258-68. PubMed ID: 16935889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid-induced bone loss in dermatologic patients: an update.
    Summey BT; Yosipovitch G
    Arch Dermatol; 2006 Jan; 142(1):82-90. PubMed ID: 16415391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of intravenous immunoglobulin therapy in autoimmune blistering diseases.
    Ahmed AR
    Int Immunopharmacol; 2006 Apr; 6(4):557-78. PubMed ID: 16504919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Benefits and risks of glucocorticoid therapy for the treatment of rheumatoid arthritis and management of glucocorticoid-induced osteoporosis].
    Suzuki Y; Wakabayashi T; Saito E; Yamada C; Suwa A
    Clin Calcium; 2009 Mar; 19(3):404-15. PubMed ID: 19252251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of the tuberculin skin test in screening for tuberculosis in dialysis patients.
    Habesoğlu MA; Torun D; Demiroglu YZ; Karatasli M; Sen N; Ermis H; Ozdemir N; Eyuboglu FO
    Transplant Proc; 2007 May; 39(4):883-6. PubMed ID: 17524839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Jails, a neglected opportunity for tuberculosis prevention.
    MacNeil JR; McRill C; Steinhauser G; Weisbuch JB; Williams E; Wilson ML
    Am J Prev Med; 2005 Feb; 28(2):225-8. PubMed ID: 15710280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tuberculosis in the 21st century].
    Yossepowitch O; Dan M
    Harefuah; 2007 Mar; 146(3):206-11, 245. PubMed ID: 17460929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany].
    Schaberg T; Hauer B; Haas WH; Hohlfeld J; Kropp R; Loddenkemper R; Loytved G; Magdorf K; Rieder HL; Sagebiel D
    Pneumologie; 2004 Apr; 58(4):255-70. PubMed ID: 15098162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in the screening for tuberculosis in children.
    Selekman J
    Pediatr Nurs; 2006; 32(1):73-5. PubMed ID: 16572543
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results and significance of a baseline tuberculin skin test programme among health care workers in a hospital setting].
    Gerbaudo L; Violante B
    Med Lav; 2007; 98(3):221-31. PubMed ID: 17598350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Application and problems of quantiFERON TB-2G for tuberculosis control programs--(2) clinical use of quantiFERON TB-2G].
    Kawabe Y
    Kekkaku; 2007 Jan; 82(1):61-6. PubMed ID: 17310783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for screening and treatment of cervical disease in the adolescent.
    Guido R
    J Pediatr Adolesc Gynecol; 2004 Oct; 17(5):303-11. PubMed ID: 15581775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.